Cargando…

Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions

Alternol and its oxidate isomer Alteronol are small compounds isolated from the fermentation of a mutant fungus obtained from Taxus brevifolia bark. Preclinical studies showed their potent anti-cancer activities, including attenuating cellular survival pathways, altering protein levels of cell cycle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wang, Li, Jean C., Huang, Jian, Chen, Jiepeng, Holzbeierlein, Jeffrey, Li, Benyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670956/ https://www.ncbi.nlm.nih.gov/pubmed/33224877 http://dx.doi.org/10.3389/fonc.2020.568110

Ejemplares similares

Alternol triggers immunogenic cell death via reactive oxygen species generation
por: Li, Changlin, et al.
Publicado: (2021)

Alternol, a natural compound, exerts an anti‐tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways
por: Zuo, Dongqing, et al.
Publicado: (2016)

Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis
por: Ren, Yu, et al.
Publicado: (2021)

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
por: Ren, Boxue, et al.
Publicado: (2019)

Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells
por: Bao, Yong, et al.
Publicado: (2020)

Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
por: Huang, Jian, et al.
Publicado: (2022)

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma
por: Huang, Jian, et al.
Publicado: (2022)

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
por: Jiang, Wen, et al.
Publicado: (2022)

Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis
por: Shen, Hanyuan, et al.
Publicado: (2019)

Mechanistic Studies of Anti-Hyperpigmentary Compounds: Elucidating Their Inhibitory and Regulatory Actions
por: Lam, Rosanna Y. Y., et al.
Publicado: (2014)

TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers
por: Huang, Jian, et al.
Publicado: (2022)

Editorial: Investigating drugs used off-label in various cancers
por: Liu, Wang, et al.
Publicado: (2023)

The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers
por: Zhu, Runzhi, et al.
Publicado: (2021)

Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers
por: Wang, Jinhu, et al.
Publicado: (2021)

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
por: Muniyan, Sakthivel, et al.
Publicado: (2022)

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs
por: Wen, Hai-ni, et al.
Publicado: (2022)

miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression
por: Ren, Wenbiao, et al.
Publicado: (2021)

Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers
por: He, Chenchen, et al.
Publicado: (2023)

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
por: Du, Jiajia, et al.
Publicado: (2021)

An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins
por: Wei, Jun, et al.
Publicado: (2011)

Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment
por: Chen, Fengqian, et al.
Publicado: (2021)

Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
por: Romano, Alessandra, et al.
Publicado: (2021)

Advances in Stigmasterol on its anti-tumor effect and mechanism of action
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
por: Seidel, Judith A., et al.
Publicado: (2018)

PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma
por: Tao, Chang, et al.
Publicado: (2022)

Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine)
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2019)

Nicotinamide–Ponatinib Analogues as Potent Anti-CML and Anti-AML Compounds
por: Larocque, Elizabeth, et al.
Publicado: (2020)

DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
por: Mahmood, Niaz, et al.
Publicado: (2019)

Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
por: Yousefnia, Saghar, et al.
Publicado: (2020)

Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
por: Zheng, Yannan, et al.
Publicado: (2022)

Potent Antioxidant and Anti-Tyrosinase Activity of Butein and Homobutein Probed by Molecular Kinetic and Mechanistic Studies †
por: Pan, Wenkai, et al.
Publicado: (2023)

Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo
por: Zhang, C, et al.
Publicado: (2014)

Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer
por: Zhu, Shilan, et al.
Publicado: (2022)

Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment
por: Dahlem, Charlotte, et al.
Publicado: (2022)

Mechanistic Targets and Phytochemical Strategies for Breaking the Obesity-Cancer Link
por: Ford, Nikki A., et al.
Publicado: (2013)

“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
por: Malik, Astha, et al.
Publicado: (2021)

Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers
por: Shi, Jianguang, et al.
Publicado: (2021)

Corrigendum: Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer
por: Zhu, Shilan, et al.
Publicado: (2022)

Stress Granules in the Anti-Cancer Medications Mechanism of Action: A Systematic Scoping Review
por: Asadi, Mohammad Reza, et al.
Publicado: (2021)

Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration
por: Guan, Rui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cvo0qrplj0s4407ds2c3b8avag